Rubius Therapeutics, Inc. Gains 45.06%

Wed, Dec 28, 2022 at 07:05 PM
Rubius Therapeutics, Inc. Gains 45.06%

Rubius Therapeutics, Inc. (RUBY:NASDAQ) shot up at $0.24, representing a gain of 45.1%. On Wed, Dec 28, 2022, RUBY:NASDAQ hit a New 2-Week High of $0.24. From Wed, Dec 14, 2022, the stock recorded 55.56% Up Days and 30.00% Green Days

The stock spiked on Wed, Dec 28, 2022 at $0.42 with a volume of 18M+.

About Rubius Therapeutics, Inc. (RUBY:NASDAQ)

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.